Monkeypox: A review of a zoonotic disease of global public health concern

Yusuf Amuda Tajudeen ^1,2 , Habeebullah Jayeola Oladipo ^1,3 * , Abdulbasit Opeyemi Muili ⁴, Joy Ginika Ikebuaso ⁵

Cited by CrossRef: 7

1- Acharya A, Kumar N, Singh K, Byrareddy S. “Mpox in MSM: Tackling stigma, minimizing risk factors, exploring pathogenesis, and treatment approaches”. Biomedical Journal. 2025;48(1):100746 [Crossref]

2- Sirohiya P. Mpox and cancer: Dual dangers. Medical Journal Armed Forces India. 2025;81:S181 [Crossref]

3- Silva E, Torres L, Alves A, Silva A, Carvalho P, Silva T, Silva V, Silva F, Alves L, Melo M, Gonçalves L, Oliveira J, Silva L, Silva H, Soares R. MONKEYPOX: ASPECTOS EPIDEMIOLÓGICOS, CLÍNICOS E PERSPECTIVAS PARA O CONTROLE DA DOENÇA EMERGENTE. Rev Contemp. 2025;5(3):e7755 [Crossref]

4- Fatima H, Arif M, Chatha M, Ali Q, Batool K. Transmission dynamics and evolution of Monkeypox virus (MPXV) during the 2024 global outbreak: implications for surveillance, treatment and vaccination. Vacunas (English Edition). 2026;27(1):500628 [Crossref]

5- Sokunbi T, Jimoh L, Adegunna V, Mowobi D. Addressing the susceptibility of Africans to monkeypox disease: a commentary. Discov Public Health. 2024;21(1) [Crossref]

6- Duarte P, Adesola R, Priyadarsini S, Singh R, Shaheen M, Ogundijo O, Gulumbe B, Lounis M, Samir M, Govindan K, Adebiyi O, Scott G, Ahmadi P, Mahmoodi V, Chogan H, Gholami S, Shirazi O, Moghadam S, Jafari N, Shahabinejad F, Subbaram K, Fawzy M, Rehman A, Tazerji S. Unveiling the Global Surge of Mpox (Monkeypox): A comprehensive review of current evidence. The Microbe. 2024;4:100141 [Crossref]

7- Saloni S, Saloni B, Saloni A, Saloni A, Saloni A, Saloni P. Global resurgence of monkeypox (mpox) virus: a review of current outbreaks and public health strategies. theevi. 2024;2(3) [Crossref]

8- Shoaib H. Monkeypox as a potential emerging pandemic: a discussion on future risks and preparedness in Saudi Arabia. Front Public Health. 2023;11 [Crossref]

9- Singkun A, Phibarn W, Intharachuti W, Derramon A, Kimise T. Factors Predicting the Intention to Engage in Self-Protective Behavior against Monkeypox Infection among Thai People. Journal of Health Research. 2024;38(4) [Crossref]

10- Mushebenge A, Mphuthi D. Deciphering Drug Repurposing Strategies: Antiviral Properties of Candidate Agents Against the Mpox Virus. Sci Pharm. 2025;93(4):51 [Crossref]

11- Rajak P, Ganguly A, Dey S, Sen K. In silico targeting of pox virus proteins to repurpose triterpenes against monkeypox infection . Comput Struct Biotechnol Rep. 2025;2 [Crossref]

12- Makokha G, Abuduwaili M, Chayama K, Hijikata M. What is the future of Mpox outbreak?. Virology. 2025;610:110618 [Crossref]

13- Abdulrahim A, Gulumbe B, Idris I, Abubakar T, Sobur K, Lawal A, Shehu A. Strengthening global health preparedness amid Mpox spread in Africa. Discov Public Health. 2025;22(1) [Crossref]

14- Yu Y, Meza K, Colbert C, Hoft D, Jaunarajs A, Blazevic A, Frey S, Abate G. Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox Immunity. Vaccines. 2024;13(1):27 [Crossref]

15- L. S. D, R. D, A. M, N. H, Begum R, S. N, M. M, S. A. Emerging threats of monkeypox virus in 2024: current insights and future directions. Future Science OA. 2025;11(1) [Crossref]

16- Attique L, Jamal S, Gulistan T, Haider A, Amraiz D, Abbasi S, Ahmad S, Aljasir M. Multiepitope-Based Peptide Vaccine Against A35R Glycoprotein and E8L Membrane Protein of Monkeypox Virus Using an Immunoinformatics Approach. Biology. 2026;15(7):524 [Crossref]

17- He Y, Tang Y, Wang C, Zhou Z, Li W, Tian M. The Global Health Threat of Monkeypox Virus: Understanding Its Biology, Transmission, and Potential Therapeutic Interventions. IDR. 2023;Volume 16:7759 [Crossref]

18- Fatima H, Arif M, Chatha M, Ali Q, Batool K. Transmission dynamics and evolution of Monkeypox virus (MPXV) during the 2024 global outbreak: implications for surveillance, treatment and vaccination. Vacunas. 2026;27(1):500628 [Crossref]

19- Osborne A, Abu A, Vandy A. Sociodemographic factors of knowledge, conspiracy beliefs, and attitudes toward Mpox among healthcare workers in Sierra Leone. Vaccine: X. 2026;29:100799 [Crossref]

20- Ayoola M, Ajagbe A, Oyeleye B, Olajimbiti C, Zakariya M, Wadan A, Usende I. MPOX transmission risks and biosafety protocols in laboratory animal research. Lab Anim Res. 2026;42(1) [Crossref]

21- Zyoud S. Global Mapping and Visualization Analysis of One Health Knowledge in the COVID-19 Context. Environ�Health�Insights. 2024;18 [Crossref]

22- Mohamed Abdoul-Latif F, Ainane A, Mohamed H, Merito Ali A, Houmed Aboubaker I, Jutur P, Ainane T. Mpox Resurgence: A Multifaceted Analysis for Global Preparedness. Viruses. 2024;16(11):1737 [Crossref]

23- Nka A, Bouba Y, Fokam J, Ka'e A, Gabisa J, Mandeng N, Mfonkou D, Ambe C, Mballa Mpouel M, Djikeussi T, Tchounga B, Ayuk Ngwese D, Njume D, Mbala Nomo S, Ngoufack Jagni Semengue E, Tiotsia Tsapi A, Fokou B, Simo Kamdem I, Tommo Tchouaket M, Takou D, Pabo W, Sosso S, Tandi E, Esso L, Etoundi Mballa G, Zoung-Kanyi Bissek A, Gregory Edie H, Ndembi N, Colizzi V, Perno C, Ndjolo A. Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparedness. Front Public Health. 2024;12 [Crossref]

24- Afzal M, Sah A. Effectiveness of Public Health Campaigns on Mpox Awareness and Prevention in Rural India. Infect Dis Clin Pract. 2025;33(3) [Crossref]

25- Yappalparvi A, Gaidhane S, Padmapriya G, Kaur I, Lal M, Iqbal S, Prasad G, Pramanik A, Sharma P, Malik P, Vishwakarma T, Punia A, Jagga M, Mehta R, Sah S, Shabil M, Satapathy P, Bushi G, Parsa A, Kabir R. Prevalence of Mpox Vaccine Acceptance Among Students: A Systematic Review and Meta-Analysis. Vaccines. 2025;13(2):183 [Crossref]

26- Ali E, Khardali A, Alam N, Meraya A, Thaibah H, Hassan D, Elmobark M, Aladwani A, Mohanan A, Bakri H, Mashraqi Z, Salhabi A. Knowledge and attitude of human Mpox viral infection among pharmacy students in Jazan University: a web based cross-sectional study. Front Public Health. 2025;13 [Crossref]